Specificity of 89Zr-trastuzumab tumor uptake was demonstrated by the presence of only weak 89Zr-anti-STEAP1 signal in separate Fo2-1282 brain grafts (Fig. 2, right). Here, STEAP1 is linked to neoplasm.